PELAYANAN KEFARMASIAN DI BEBERAPA APOTEK DI INDONESIA PADA ERA PANDEMI COVID-19
Downloads
Latar Belakang: COVID-19 telah mempengaruhi aspek kesehatan. Apoteker perlu merumuskan strategi dan inovasi dalam menghadapi pandemi ini untuk memberikan pelayanan kefarmasian kepada masyarakat. Tujuan: Penelitian ini bertujuan untuk mengetahui dampak, pelayanan kefarmasian, dan inovasi pelayanan kefarmasian di apotek komunitas Indonesia pada masa pandemi COVID-19. Metode: Penelitian dilakukan dengan cara observasional dan desain cross-sectional. Data dikumpulkan melalui kuesioner yang disebarkan secara daring. Sebanyak 96 apoteker berpartisipasi dalam penelitian ini. Data dianalisis secara deskriptif dan distribusi data ditampilkan berdasarkan frekuensi dan persentase dari hasil kuesioner. Hasil: Hasil penelitian menunjukkan bahwa pandemi COVID-19 ini berdampak pada (60,4%) pelayanan apotek di Indonesia karena terjadi peningkatan permintaan beberapa produk farmasi (suplemen, vitamin, dan alat kesehatan) yang dapat menekan sistem rantai pasokan obat. Pelayanan kefarmasian saat COVID-19 sudah diterapkan oleh beberapa apotek di Indonesia (31,25%, n=30) sesuai Pedoman Kemenkes RI terkait Pedoman Kesiapsiagaan COVID-19 Rev 02 Tahun 2020. Selain itu, beberapa apotek di Indonesia (71,88%, n=69) telah menerapkan E-pharmacy, pembayaran nontunai, layanan resep dan swamedikasi secara daring, serta pengiriman obat ke rumah pasien di masa pandemi COVID-19. Kesimpulan: Dampak pandemi COVID-19 pada pelayanan kefarmasian di apotek komunitas yakni penerapan e-pharmacy dan sebagian besar apotek telah menerapkan prosedur operasional yang sesuai.
Kata Kunci: apotek komunitas, COVID-19, pelayanan kefarmasian, apoteker, Indonesia
Bahlol, M, & Dewey, RS 2020, 'Pandemic preparedness of community pharmacies for COVID-19', Research in Social and Administrative Pharmacy, May, 0–1 https://doi.org/10.1016/j.sapharm.2020.05.009.
Bahrun, S, Alifah, S, Mulyono, S 2017, 'Rancang Bangun Sistem Informasi Survey Pemasaran dan Penjualan Berbasis Web', Jurnal Transistor Elektro Dan Informatika (TRANSISTOR EI, 2(2), 81–88.
Dzingirai, B, Matyanga, CMJ, Mudzviti, T, Siyawamwaya, M, Tagwireyi, D 2020, 'Risks to the community pharmacists and pharmacy personnel during COVID-19 pandemic: Perspectives from a low-income country', In Journal of Pharmaceutical Policy and Practice, BioMed Central, Vol. 13, Issue 1.
Fallucchi, F, Faravelli, M, Quercia, S 2020, 'Fair allocation of scarce medical resources in the time of COVID-19: what do people think?', Journal of Medical Ethics, 382, medethics-2020-106524.
Hedima, EW, Adeyemi, MS, Ikunaiye, NY 2020, 'Community Pharmacists: On the frontline of health service against COVID-19 in LMICs', Research in Social and Administrative Pharmacy, https://doi.org/10.1016/j.sapharm.2020.04.013.
Hoti, K, Jakupi, A, Hetemi, D, Raka, D, Hughes, J, Desselle, S 2020, 'Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information', International Journal of Clinical Pharmacy, 42(4), 1197–1206.
International Pharmaceutical Federation 2017, 'Fip Statement of Policy Role of Pharmacist in disaster management', FIP, www.fip.org/statements.
Pedoman Kemenkes RI tentang Pedoman Kesiapsiagaan COVID-19 Rev 02 Tahun 2020 2020.
Koster, ES, Philbert, D, Bouvy, ML 2020, 'Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies', Research in Social and Administrative Pharmacy, June, 10–12.
Permenkes 2014, Berita Negara, Menteri Kesehatan Republik Indonesia Peraturan Menteri Kesehatan Republik Indonesia, Nomor 65(879), 2004–2006.
Singh, H , Majumdar, A, Malviya, N 2020, 'E-PHARMACY IMPACTS ON SOCIETY AND PHARMA SECTOR IN ECONOMICAL PANDEMIC SITUATION: A REVIEW', Journal of Drug Delivery and Therapeutics, 10(3-s), 335–340.
World Health Organization 2020, Coronavirus. https://www.who.int/health-topics/coronavirus#tab=tab_3.
Zheng, SQ, Yang, L, Zhou, PX, Li, HB, Liu, F, Zhao, RS 2020, 'Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. In Research in Social and Administrative Pharmacy', Elsevier Inc, https://doi.org/10.1016/j.sapharm.2020.03.012.
In order to be accepted and published by JFK, author(s) submitting the article manuscript should complete all the review stages. By submitting the manuscript, the author(s) agreed to these following terms:
1. Copyright of the article is transferred to the journal (JFK), by the knowledge of the author, whilst the moral right of the publication belongs to the author. The intended copyright includes the rights to publish articles in various forms (including reprints). JFK maintain the publishing rights to the published articles.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
The Copyright Transfer Agreement Form can be downloaded ON THIS FORM.
Jurnal Farmasi Komunitas (JFK) by Unair is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
